Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01879189 · ClinicalTrials.gov registry record · NA
PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,302
- Enrollment target
NCT01879189: Completed NA study, sponsored by University of Pennsylvania.
NCT01879189 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,302 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01879189, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,302 participants
- Enrollment target
Study Summary
In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Pennsylvania has created a personal breast cancer screening decision aid tool. This tool will be pilot tested, and then implemented and tested in nine primary care and OB/GYN practices within the University of Pennsylvania Health System.
Primary Outcome
Medical charts of women in both the intervention and control groups of the study will be analyzed to determine if these women initiated breast cancer screening (mammography) correlated to their personal risk of breast cancer as displayed by the decision aid.
Interventions
- BEHAVIORAL Breast Cancer Screening Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,302 participants |
| Start Date | 2013-09 |
| Est. Completion | 2017-11 |
| Phase | NA |
What the finished NCT01879189 record still lists
NCT01879189 is an interventional study that assigns participants to a tested intervention. Its 1,302 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Breast Cancer Screening Decision Aid is the first listed.
NCT01879189 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01879189 about?
NCT01879189 is a clinical study titled "PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk". In order to better communicate personal risk of breast cancer to women who have not yet initiated breast cancer screening (mammography), The Annenberg School of Communication at the University of Pennsylvania has created a personal breast cancer screening decision aid tool. This tool will be pilot t...
What is the current status of trial NCT01879189?
This trial is currently completed. It is a NA study. The enrollment target is 1,302 participants. The study started on 2013-09. Estimated completion is 2017-11.
What interventions are being tested in trial NCT01879189?
The interventions under investigation include: Breast Cancer Screening Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT01879189?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01879189's enrollment target sits among peer trials
1,302 76th of 2000 higher than 1,925 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04474223 · 1,300 participants · Phase 3
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
- NCT04792684 · 1,300 participants
Collection of Samples USOPTIVAL Study
- NCT05166694 · 1,300 participants · NA
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
- NCT05282654 · 1,300 participants · NA
Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia